Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation

Clinical trial NCT06426758 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06426758
Sponsor: Xiao-Ming Mao
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Graves Disease Graves' Disease in Remission Epstein-Barr Virus

Start date: 2024-05-30
Primary completion: 2026-09-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.